Literature DB >> 3224361

Distinct interactions between Ca2+/calmodulin and neurotransmitter stimulation of adenylate cyclase in striatum and hippocampus.

M K Ahlijanian1, D M Cooper.   

Abstract

1. Ca2+ and cAMP both act as intracellular second messengers of receptor activation. In neuronal tissue, Ca2+ acting via calmodulin can elevate cAMP levels. This regulation by Ca2+ provides a means whereby the elevation of intracellular [Ca2+] might modulate cAMP generation. 2. In the present studies, the impact of the Ca2+/calmodulin regulation on receptor-mediated stimulation of activity is compared in striatum and hippocampus--regions of differing sensitivity to Ca2+/camodulin. Ca2+/calmodulin stimulated striatal and hippocampal adenylate cyclase activity by 1.4- and 2.7-fold respectively, while dopamine and vasoactive intestinal peptide (VIP) stimulated the enzyme activity of these respective regions by 1.3- and 2-fold. 3. In the presence of Ca2+/calmodulin, the dopamine dose-response curve in the striatum was shifted upward, without alteration of the slope of the curve or of the maximal stimulation of activity elicited by dopamine. In the hippocampus, the ability of VIP to stimulate adenylate cyclase activity was reduced by the presence of calmodulin. 4. The dose dependence of these actions of calmodulin was examined. In the striatum, the stimulation of adenylate cyclase activity by 0.1 to 0.3 microM calmodulin obscured dopamine stimulation, while 1 to 10 microM was additive with the dopamine stimulation. In the hippocampus, all concentrations of calmodulin (0.1 to 10 microM) reduced VIP-mediated stimulation of enzyme activity. 5. These data suggest that the ratio of calmodulin-sensitive to calmodulin-insensitive adenylate cyclase activity varies in different rat brain regions and that, in those regions in which this ratio is low (e.g., rat striatum and most peripheral systems), calmodulin- and receptor-mediated activation of adenylate cyclase activity will be additive, while in those systems in which this ratio is high (e.g., most of the central nervous system), calmodulin will reduce receptor-mediated stimulation of enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3224361     DOI: 10.1007/bf00711229

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  18 in total

1.  Protein activator of cyclic 3':5'-nucleotide phosphodiesterase of bovine or rat brain also activates its adenylate cyclase.

Authors:  W Y Cheung; L S Bradham; T J Lynch; Y M Lin; E A Tallant
Journal:  Biochem Biophys Res Commun       Date:  1975-10-06       Impact factor: 3.575

2.  Regulation of dopamine stimulation of striatal adenylate cyclase by an endogenous Ca++ -binding protein.

Authors:  M E Gnegy; P Uzunov
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

3.  Regulation of adenylate cyclase from glial tumor cells by calcium and a calcium-binding protein.

Authors:  M A Brostrom; C O Brostrom; B M Breckenridge; D J Wolff
Journal:  J Biol Chem       Date:  1976-08-10       Impact factor: 5.157

4.  Synergistic activation of bovine cerebellum adenylate cyclase by calmodulin and ?-adrenergic agonists.

Authors:  A Malnoë; E A Stein; J A Cox
Journal:  Neurochem Int       Date:  1983       Impact factor: 3.921

5.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

Review 6.  Calmodulin.

Authors:  C B Klee; T H Crouch; P G Richman
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

7.  Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.

Authors:  D M Cooper; C M Bier-Laning; M K Halford; M K Ahlijanian; N R Zahniser
Journal:  Mol Pharmacol       Date:  1986-02       Impact factor: 4.436

8.  Calmodulin may play a pivotal role in neurotransmitter-mediated inhibition and stimulation of rat cerebellar adenylate cyclase.

Authors:  M K Ahlijanian; D M Cooper
Journal:  Mol Pharmacol       Date:  1987-07       Impact factor: 4.436

9.  Regional and subcellular calmodulin content of rat brain.

Authors:  B Hoskins; C K Burton; D D Liu; A B Porter; I K Ho
Journal:  J Neurochem       Date:  1986-01       Impact factor: 5.372

10.  Role of calmodulin in the effect of guanyl nucleotides on rat hippocampal adenylate cyclase: involvement of adenosine and opiates.

Authors:  J M Girardot; J Kempf; D M Cooper
Journal:  J Neurochem       Date:  1983-09       Impact factor: 5.372

View more
  6 in total

1.  Differential activation of adenylyl cyclases by spatial and procedural learning.

Authors:  J L Guillou; G M Rose; D M Cooper
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

Review 2.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory.

Authors:  J Lisman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  A role for calmodulin-stimulated adenylyl cyclases in cocaine sensitization.

Authors:  Derek P DiRocco; Zachary S Scheiner; Carlos Balet Sindreu; Guy C-K Chan; Daniel R Storm
Journal:  J Neurosci       Date:  2009-02-25       Impact factor: 6.167

5.  Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.

Authors:  Kelly E Bosse; Jennifer L Charlton; Laura L Susick; Brooke Newman; Andrew L Eagle; Tiffany A Mathews; Shane A Perrine; Alana C Conti
Journal:  J Neurochem       Date:  2015-09-10       Impact factor: 5.372

6.  Depotentiation from Potentiated Synaptic Strength in a Tristable System of Coupled Phosphatase and Kinase.

Authors:  Mengjiao Chen; Wei Ren; Xingang Wang
Journal:  Front Comput Neurosci       Date:  2016-10-19       Impact factor: 2.380

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.